CAMPs, the main core technology platform of
Xcell Therapeutics, aims to develop optimized
media for the users who works on diverse cell types.
Currently, we are developing customized media for diverse cells by grafting CAMPs technology,
and we have various pipelines by applying and expanding CAMPs.
With the successful launch of CellCor Serum-free defined media for human mesenchymal stem cells, we have developed Chemically Defined media.
With the accumulated expertise regarding CAMPs technology, we have completed the development of media for dermal papilla cells(DPC) and media for keratinocytes, and additional product launches are planned.
Moreover, we are developing media for immune cells (NK/T) and media for stem cells derived exosomes.
With our technology, we have expanded our business area by launching Viral Transport Medium (VTM) and cosmetic ingredients.
CAMPs, the main core technology platform of Xcell Therapeutics, aims to develop optimized media for the users who works on diverse cell types.
1,000 +Teanlational Studies
< 15Approved Products